Dopamine and Mesenchymal Stem Cells 53. Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, et al. (2002) Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113: 155–166. 54. Vargovic P, Ukropec J, Laukova M, Cleary S, Manz B, et al. (2011) Adipocytes as a new source of catecholamine production. FEBS Lett 585: 2279–2284. 55. Shi E, Kazui T, Jiang X, Washiyama N, Yamashita K, et al. (2007) Therapeutic benefit of intrathecal injection of marrow stromal cells on ischemia-injured spinal cord. Ann Thorac Surg 83: 1484–1490. 56. Ferrari A, Hannouche D, Oudina K, Bourguignon M, Meunier A, et al. (2001) In vivo tracking of bone marrow fibroblasts with fluorescent carbocyanine dye. J Biomed Mater Res 56: 361–367. 57. Bartunek J, Croissant JD, Wijns W, Gofflot S, de Lavareille A, et al. (2007) Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyo- genic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol 292: H1095–H1104. 58. Ponte AL, Marais E, Gallay N, Langonne´ A, Delorme B, et al. (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737–1745. 59. Ganguly S, Basu B, Shome S, Jadhav T, Roy S, et al. (2010) Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)- induced gastric cancer cell proliferation via up-regulation of Kr u¨ppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation. Am J Pathol 177: 2701–2707. 60. Chiou WF, Don MJ (2007) Cryptotanshinone inhibits macrophage migration by impeding F-actin polymerization and filopodia extension. Life Sci 81: 109–114. PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e31682